Logo image of BRYN.DE

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:BRYN - US0846707026 - Common Stock

424.35 EUR
-4.1 (-0.96%)
Last: 12/22/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BRYN. BRYN was compared to 59 industry peers in the Financial Services industry. Both the profitability and the financial health of BRYN get a neutral evaluation. Nothing too spectacular is happening here. BRYN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BRYN suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BRYN was profitable.
BRYN had a positive operating cash flow in the past year.
Of the past 5 years BRYN 4 years were profitable.
BRYN had a positive operating cash flow in each of the past 5 years.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

With a decent Return On Assets value of 5.50%, BRYN is doing good in the industry, outperforming 77.97% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.66%, BRYN is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
BRYN has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: BRYN outperforms 55.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 9.75%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROIC 4.53%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of BRYN (18.13%) is better than 72.88% of its industry peers.
In the last couple of years the Profit Margin of BRYN has declined.
BRYN's Operating Margin of 16.72% is in line compared to the rest of the industry. BRYN outperforms 55.93% of its industry peers.
BRYN's Operating Margin has improved in the last couple of years.
The Gross Margin of BRYN (17.71%) is worse than 62.71% of its industry peers.
In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
Compared to 1 year ago, BRYN has less shares outstanding
Compared to 5 years ago, BRYN has less shares outstanding
Compared to 1 year ago, BRYN has an improved debt to assets ratio.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.36, BRYN perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
The Debt to FCF ratio of BRYN is 6.58, which is on the high side as it means it would take BRYN, 6.58 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BRYN (6.58) is comparable to the rest of the industry.
BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
BRYN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. BRYN outperforms 71.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Altman-Z 1.36
ROIC/WACC1.41
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

BRYN has a Current Ratio of 1.33. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
BRYN's Current ratio of 1.33 is in line compared to the rest of the industry. BRYN outperforms 52.54% of its industry peers.
BRYN has a Quick Ratio of 1.11. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, BRYN is in line with its industry, outperforming 47.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.11
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

4

3. Growth

3.1 Past

BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.97%, which is quite good.
BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.78% yearly.
The Revenue has been growing slightly by 0.60% in the past year.
Measured over the past years, BRYN shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%

3.2 Future

Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.26% on average per year.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-0.45%
EPS Next 2Y0.3%
EPS Next 3Y1.64%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
Compared to the rest of the industry, the Price/Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 98.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.61, BRYN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BRYN is valued cheaper than 98.31% of the companies in the same industry.
BRYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 89.83% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 98.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.04
EV/EBITDA 0.64
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.3%
EPS Next 3Y1.64%

0

5. Dividend

5.1 Amount

BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (12/22/2025, 7:00:00 PM)

424.35

-4.1 (-0.96%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-01 2025-11-01/bmo
Earnings (Next)02-20 2026-02-20/bmo
Inst Owners27.78%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap611.06M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target451.08 (6.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)-0.14%
PT rev (3m)-0.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)2.63%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
P/S 0
P/FCF 0.04
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 0.64
EPS(TTM)28979.86
EY6829.24%
EPS(NY)28342.02
Fwd EY6678.92%
FCF(TTM)11459
FCFY2700.37%
OCF(TTM)23360.4
OCFY5504.98%
SpS220647.39
BVpS413959.92
TBVpS343020
PEG (NY)N/A
PEG (5Y)0
Graham Number519539
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROCE 5.61%
ROIC 4.53%
ROICexc 4.87%
ROICexgc 5.82%
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
FCFM 5.19%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Debt/EBITDA 1.69
Cap/Depr 151.95%
Cap/Sales 5.39%
Interest Coverage 12.22
Cash Conversion 52.22%
Profit Quality 28.65%
Current Ratio 1.33
Quick Ratio 1.11
Altman-Z 1.36
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.45%
EPS Next 2Y0.3%
EPS Next 3Y1.64%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


Can you provide the valuation status for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


What is the profitability of BRYN stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for BRYN stock?

The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.


What is the expected EPS growth for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

The Earnings per Share (EPS) of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is expected to decline by -0.45% in the next year.